Inactive Instrument

News Bone Medical Limited Australian S.E.

Equities

AU0000BNEDC4

End-of-day quote Australian S.E. Other stock markets
- ^AUD	-

02:08am	Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication	MT
06-12	Botanix Pharmaceuticals Submits Last Label Materials for Sofdra FDA Approval	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication	01:08am	MT
Botanix Pharmaceuticals Submits Last Label Materials for Sofdra FDA Approval	06-12	MT
Evans & Partners Starts Botanix Pharmaceuticals at Speculative Buy With AU$0.55 Price Target	05-21	MT
Euroz Hartleys Adjusts Botanix Pharmaceutical’s Price Target to AU$0.33 From AU$0.30, Keeps at Speculative Buy	05-13	MT
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index	03-17	CI
Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
US FDA Accepts Resubmission of Botanix Pharmaceuticals' Topical Medication	01-22	MT
Botanix Pharmaceuticals Completes US FDA Resubmission for Topical Medication; Shares Gain 3%	12-21	MT
Botanix Pharmaceuticals Completes Human Factors Validation Study for Topical Medication; Shares Rise 3%	12-14	MT
Botanix Pharmaceuticals Secures US FDA Feedback for Topical Medication	12-04	MT
Botanix Pharmaceuticals Limited Receives Feedback from FDA	12-03	CI
Botanix Pharmaceuticals Completes Nearly AU$14 Million Institutional Placement	12-01	MT
Botanix Pharmaceuticals to Raise AU$13.5 Million in Placement; Shares Fall 3%	11-27	MT
Acne Vulgaris Pipeline\| Clinical Trials, Key Companies - Novan, Bausch Health AOBiome, Ascletis Pharmaceuticals, AnaptysBio, Botanix Pharmaceuticals	11-07	AQ
Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27/10/23	AQ
Botanix Pharmaceuticals Signs Telehealth Deal for Dermatological Product	24/10/23	MT
Botanix Pharmaceuticals Secures Conditional US FDA Clearance for Use of 'Sofra' Trade Name	17/10/23	MT
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX Emerging Companies Index	18/09/23	CI
Botanix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23	CI
Botanix Pharmaceuticals Promotes COO to CEO	25/08/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bone Medical Limited Australian S.E.

Equities

AU0000BNEDC4

Summary

Filters